バイオ＆ヘルスケア
事業部
WAFTEC BIO

参考文献

• ピーナッツ−ガラクトマンナン複合体の低アレルゲン性とピーナッツアレルギーモデルマウスにおける免疫療法の効果

  中野泰至，関野有紀，影島宏紀，下条 直樹

  臨床免疫・アレルギー科 83(3): 219-224, 2025.

• Safety of local nasal immunotherapy using hypoallergenic birch pollen ointment in patients with pollen-food allergy syndrome: A preliminary study of five cases.

  Komatsuzaki K, Otani Y, Kageshima H, Sekino Y, Suzuki Y, Ugajin T, Tamaoka M, Yorozu P, Hanazawa R, Hirakawa A, Murakami D, Miyazaki Y.

  Allergol Int. 2025 Apr;74(2):336-339.

• Low allergenicity and immunotherapeutic efficacy of peanut-galactomannan conjugate in a mouse model of peanut allergy.

  Nakano T, Sekino Y, Yamamoto T, Sato H, Sato N, Yamaide F, Kageshima H, Inoue Y, Hamada H, Shimojo N.

  Pediatr Allergy Immunol. 2024;35(7):e14191.

• Local nasal immunotherapy with birch pollen-galactomannan conjugate-containing ointment in mice and humans.

  Komatsuzaki K, Kageshima H, Sekino Y, Suzuki Y, Ugajin T, Tamaoka M, Hanazawa R, Hirakawa A, Miyazaki Y.

  Allergol Int. 2024;73(2):290-301.

• 腸管免疫を利用したスギ花粉症に対する新しい経口免疫療法.

  村上大輔.

  医学のあゆみ 264(12): 1055-1056, 2018.

• Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial.

  Murakami D, Sawatsubashi M, Omori H, Saito A, Kato A, Komune S, Nakagawa T.

  Sci Rep. 2017;7:46142.

• Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.

  Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.

  Auris Nasus Larynx. 2016;43(1):50-5.

• Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.

  Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.

  Allergol Int. 2015;64(2):161-8.

• Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.

  Murakami D, Kubo K, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.

  Auris Nasus Larynx. 2014;41(4):350-8.

• 花粉症の薬物治療と新しい免疫療法.

  澤津橋基広, 村上大輔, 吉川沙耶花, 小宗静男.

  臨牀と研究 89(3): 397-400, 2012.

• Effects of various saccharides on the masking of epitope sites and uptake in the gut of cedar allergen Cry j 1-saccharide conjugates by a naturally occurring Maillard reaction.

  Aoki R, Saito A, Azakami H, Kato A.

  J Agric Food Chem. 2010;58(13):7986-7990.

• Reduction of antigenicity of Cry j 1, a major allergen of Japanese cedar pollen, by thermal denaturation.

  Aoki R, Saito A, Usui M, Azakami H, Kato A.

  J Agric Food Chem. 2009;57(11):4995-9.

• Reduction of antigenicity of Cry j I, major allergen of Japanese cedar pollen, by the attachment of polysaccharides.

  Usui M, Saito A, Taniguchi N, Nishijima N, Azakami H, Kato A.

  Biosci Biotechnol Biochem. 2003;67(11):2425-2430.